VICTOR A. LEVIN, M.D.
Neurology at Holcombe Blvd, Houston, TX
License number
Texas H6000
Category
Neurology
Type
Clinical Neurophysiology
Address
Address
1515 Holcombe Blvd, Houston, TX 77030
Phone
(713) 792-6161
(713) 792-2991
(713) 792-2991
Personal information
See more information about VICTOR A. LEVIN at radaris.comName
Address
Phone
1005 Shepherd Dr, Houston, TX 77019
1005 S Shepherd Dr, Houston, TX 77019
6344 Vanderbilt St, Houston, TX 77005
Organization information
See more information about VICTOR A. LEVIN at bizstanding.comVictor Levin MD
1515 Holcombe Blvd, Houston, TX 77030
Industry:
Oncology, Neurologist
Phone:
(713) 792-6161 (Phone)
Victor Alan Levin
Professional information
Dr. Victor A Levin, Chicago IL - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Neurology)
Address:
1700 E 56Th St SUITE 801, Chicago 60637
49 Elizabeth Cir, Greenbrae 94904
49 Elizabeth Cir, Greenbrae 94904
Certifications:
Neurology, 1976
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1700 E 56Th St SUITE 801, Chicago 60637
49 Elizabeth Cir, Greenbrae 94904
Ben Taub General Hospital
1504 Taub Loop, Houston 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston 77030
49 Elizabeth Cir, Greenbrae 94904
Ben Taub General Hospital
1504 Taub Loop, Houston 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston 77030
Education:
Medical School
University of Wisconsin / Madison
Graduated: 1966
St Louis City Hosp
Massachusetts General Hospital
University of Wisconsin / Madison
Graduated: 1966
St Louis City Hosp
Massachusetts General Hospital
Victor A Levin, Houston TX
Specialties:
Neurologist
Address:
1515 Holcombe Blvd, Houston, TX 77030
Education:
University of Wisconsin, School of Medicine and Public Health - Doctor of Medicine
Massachusetts General Hospital - Residency - Neurology
Massachusetts General Hospital - Residency - Neurology
Board certifications:
American Board of Psychiatry and Neurology Certification in Neurology (Psychiatry and Neurology)
Adjuvant Chemotherapy For Anaplastic Gliomas
US Patent:
6653351, Nov 25, 2003
Filed:
Aug 13, 2002
Appl. No.:
10/218097
Inventors:
Victor A. Levin - Houston TX
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
A61K 31195
US Classification:
514564, 514283
Abstract:
The present invention provides a combination therapy using eflomithine (DFMO) and PCV (matulane, lomustine and vincristine) in the treatment of anaplastic gliomas. In contrast to the results seen with glioblastoma multiforme, anaplastic gliomas responded better to the combination of DFMO and PCV than to either the PCV combination or DFMO alone, extending patient survival by approximately two years.
Compositions And Methods For The Direct Therapy Of Tumors
US Patent:
2007019, Aug 23, 2007
Filed:
Jan 22, 2007
Appl. No.:
11/625520
Inventors:
Victor Levin - Houston TX, US
Ehud Mendel - Columbus OH, US
Ehud Mendel - Columbus OH, US
International Classification:
A61K 51/04
US Classification:
424001650
Abstract:
The present invention provides methods for the treatment of tumors, such as spinal metastases, using compositions that permit the introduction of chemotherapeutics intratumorally while concurrently visualizing the procedure. Thus, in certain embodiments, the invention concerns a composition comprising a chemotherapeutic, an alcohol and an iodinated contrast agent (e.g., iodouracil) that may be introduced into the tumor by direct injection through the aid of an imaging device, such as a CT scanner, x-ray machine, fluoroscope or the like. The ability to visualize drug solution permits the faithful introduction of the drug directly into the tumor, as opposed to surrounding tissues, which is enabled through the use of the contrast medium.
Conditionally Replicative Adenovirus To Target The Rb And Rb-Related Pathways
US Patent:
2005026, Nov 24, 2005
Filed:
Mar 15, 2005
Appl. No.:
11/080248
Inventors:
Juan Fueyo - Houston TX, US
Athanassios Kyritsis - Stavraki, GR
W. K. Yung - Houston TX, US
Polly Lee - Houston TX, US
Victor Levin - Houston TX, US
Charles Conrad - Spring TX, US
Frederick Lang - Houstoon TX, US
Athanassios Kyritsis - Stavraki, GR
W. K. Yung - Houston TX, US
Polly Lee - Houston TX, US
Victor Levin - Houston TX, US
Charles Conrad - Spring TX, US
Frederick Lang - Houstoon TX, US
International Classification:
C12Q001/68, A61K048/00, C12N015/861
US Classification:
424093200, 435456000
Abstract:
The present invention involves a method of treating cancer using a mutant adenovirus that is targeted to cells with a mutant retinoblastoma pathway. The mutant adenovirus is able to kill the tumor cells without harming the cells with a wild type retinoblastoma pathway.
Conditionally Replicative Adenovirus To Target The Rb And Rb-Related Pathways
US Patent:
2003013, Jul 24, 2003
Filed:
Apr 17, 2002
Appl. No.:
10/124608
Inventors:
Juan Fueyo - Houston TX, US
Athanassios Kyritsis - Stavraki, GR
Polly Lee - Houston TX, US
Victor Levin - Houston TX, US
Charles Conrad - Spring TX, US
Frederick Lang - Houston TX, US
Athanassios Kyritsis - Stavraki, GR
Polly Lee - Houston TX, US
Victor Levin - Houston TX, US
Charles Conrad - Spring TX, US
Frederick Lang - Houston TX, US
International Classification:
A61K048/00, C12N007/00, C12N015/861
US Classification:
424/093200, 435/235100, 435/456000
Abstract:
The present invention involves a method of treating cancer using a mutant adenovirus that is targeted to cells with a mutant retinoblastoma pathway. The mutant adenovirus is able to kill the tumor cells without harming the cells with a wild type retinoblastoma pathway.
Inhibitors Of Protein Tyrosine Kinases
US Patent:
6100254, Aug 8, 2000
Filed:
Oct 10, 1997
Appl. No.:
8/948839
Inventors:
Raymond J. A. Budde - Bellaire TX
Jonathan A. Ellman - Oakland CA
Victor A. Levin - Houston TX
Gary E. Gallick - Kingwood TX
Robert A. Newman - Sugar Land TX
Jonathan A. Ellman - Oakland CA
Victor A. Levin - Houston TX
Gary E. Gallick - Kingwood TX
Robert A. Newman - Sugar Land TX
Assignee:
Board of Regents, The University of Texas System - Austin TX
The Regents of the University of California - Oakland CA
The Regents of the University of California - Oakland CA
International Classification:
A61K 315513, A61P 2500, C07D24316
US Classification:
514221
Abstract:
Disclosed herein are small molecule, non-peptidyl inhibitors of protein tyrosine kinases, and methods for their use. The instant inhibitors are based on a 1,4-benzodiazepin-2-one nucleus. Methods are provided for inhibition of specific protein tyrosine kinases, for example pp60. sup. c-src. Methods are further provided for the use of these inhibitors in situations where the inhibition of a protein tyrosine kinase is indicated, for example, in the treatment of certain diseases in mammals, including humans.